Sarepta said on Monday that its late-stage study testing two gene-targeted therapies for Duchenne muscular dystrophy did not ...

A long-running confirmatory trial of two of Sarepta Therapeutics’ Duchenne muscular dystrophy drugs has missed its main goal.

Researchers behind a new study say that the methods used to evaluate AI systems’ capabilities routinely oversell AI ...

Merck and Eisai's experimental combination treatment helped extend the time certain patients with advanced kidney cell cancer ...

The critics said cherry-picked statistics don’t outweigh their lived experience. Miles has said that data-driven initiatives ...

The Detroit Lions (6-3) and Philadelphia Eagles (7-2) will square off in a Week 11 matchup between two of the best teams in ...

Ophthalmologists discuss how advanced imaging, MIGS, and home monitoring are reshaping decision-making in complex glaucoma ...

The hybrid model is emerging as the framework for trustworthy AI in test analytics. It retains traceability and supports ...

The Government has a choice between outdated methods that hold back progress or compassionate, cutting-edge science that ...

Revolution Medicines, Inc. ( RVMD) Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 11, 2025 9:00 AM EST All right. So we'll get started right away. So I'd like to welcome ...

Law enforcement agencies now use constant red-and-blue lights on patrol vehicles—not for emergencies but to signal presence ...

As the Pittsburgh Penguins continue to get closer to the 20-game mark of the 2025-26 regular season (sitting at the 17-game ...